P/E ratio for PerkinElmer (PKI)
P/E ratio as of April 2024 (TTM): 15.0
According to PerkinElmer 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.9666. At the end of 2022 the company had a P/E ratio of 30.6.
P/E ratio history for PerkinElmer from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 30.6 | 23.53% |
| 2021 | 24.7 | 12.14% |
| 2020 | 22.1 | -53.43% |
| 2019 | 47.4 | 29.9% |
| 2018 | 36.5 | 32.99% |
| 2017 | 27.4 | 12.59% |
| 2016 | 24.3 | -14.11% |
| 2015 | 28.3 | -9.01% |
| 2014 | 31.2 | 10.5% |
| 2013 | 28.2 | -44.74% |
| 2012 | 51.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 37.4 | 149.83% | 🇺🇸 USA |
 Agilent Technologies A | 36.0 | 140.22% | 🇺🇸 USA |
 Becton Dickinson BDX | 41.8 | 178.96% | 🇺🇸 USA |
 Illumina ILMN | -4.60 | -130.72% | 🇺🇸 USA |
 Waters Corporation WAT | 27.3 | 82.37% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | N/A | N/A | 🇺🇸 USA |
 Bruker BRKR | 37.4 | 149.58% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -48.2 | -421.77% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.